Tower Research Capital (TRC)’s Intelligent Bio Solutions INBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.26K Sell
1,355
-1,925
-59% -$4.1K ﹤0.01% 5113
2026
Q2
$7.53K Buy
3,280
+2,030
+162% +$5.34K ﹤0.01% 4127
2026
Q1
$4.18K Sell
1,250
-10
-0.8% -$69 ﹤0.01% 4225
2025
Q4
$12K Buy
+1,260
New +$10.3K ﹤0.01% 3524
2025
Q1
– Sell
-580
Closed -$8.12K – 5483
2024
Q4
$8.12K Buy
580
+474
+447% +$7.23K ﹤0.01% 4022
2024
Q3
$1.84K Buy
106
+41
+63% +$639 ﹤0.01% 5097
2024
Q2
$1.26K Sell
65
-40
-38% -$1.02K ﹤0.01% 5180
2024
Q1
$4.43K Sell
105
-106
-50% -$4.39K ﹤0.01% 4681
2023
Q4
$8.57K Buy
211
+161
+322% +$6.32K ﹤0.01% 4497
2023
Q3
$6.12K Buy
50
+25
+100% +$5.67K ﹤0.01% 4641
2023
Q2
$8.41K Buy
25
+1
+4% +$346 ﹤0.01% 4435
2023
Q1
$8K Buy
+24
New +$22K ﹤0.01% 4635
2022
Q4
– Hold
0
– – – 6126
2022
Q2
– Sell
-2
Closed -$3K – 6279
2022
Q1
$3K Hold
2
– – ﹤0.01% 5374
2021
Q4
$8K Buy
2
+1
+100% +$4.59K ﹤0.01% 4791
2021
Q3
$8K Hold
1
– – ﹤0.01% 4540
2021
Q2
$14K Hold
1
– – ﹤0.01% 4177
2021
Q1
$7K Buy
+1
New +$17.2K ﹤0.01% 4530

Other funds holding INBS

Tower Research Capital (TRC)'s INBS Position: Q3 2026 in Review

Tower Research Capital (TRC) reduced its Intelligent Bio Solutions (INBS) stake by 59% in Q3 2026, selling an estimated $4.1K and leaving 1,355 shares worth $2.26K. The position accounts for ﹤0.01% of the portfolio, ranked #5113.

Tower Research Capital (TRC) first reported a position in INBS in Q1 2021 and has held it in 17 quarters since. The position peaked at $14K in Q2 2021. 9 funds tracked by Wall St. Rank hold INBS as of Q3 2026.

  • Tower Research Capital (TRC) held 1,355 shares of Intelligent Bio Solutions worth $2.26K as of Q3 2026.
  • Tower Research Capital (TRC) sold 1,925 Intelligent Bio Solutions shares in Q3 2026, an estimated $4.1K.
  • Intelligent Bio Solutions made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5113 holding.
  • Tower Research Capital (TRC) first reported a position in Intelligent Bio Solutions in Q1 2021 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Intelligent Bio Solutions position peaked at $14K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.